Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia
Clinical trial NCT07476183 · RECRUITING
Trial details
- NCT number
- NCT07476183
- Sponsor
- Apriligen, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-16
- Primary completion
- 2027-04-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.